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Immunization with Peptide-Functionalized
Carbon Nanotubes Enhances Virus-Specific
Neutralizing Antibody Responses
end groups and/or to the side walls of the tubes to obtain
highly soluble carbon nanotubes in organic solvents and
aqueous solutions [3–8]. In particular, 1,3-dipolar cycload-
dition reaction of azomethine ylides has emerged as
a powerful methodology for the generation of amino-
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induce adequate or appropriate responses, as well as
providing significant means of enhancing and modulat-
ing immune responses. In vaccine delivery, one impor-Summary
tant parameter to consider is the retention of antigen
conformation, which is required for the induction of anti-Functionalized carbon nanotubes (CNTs) hold a lot of
promise for application in medicinal chemistry. Based body responses with the right specificity. In a recent
study, we demonstrated the development of a versatileon a method for preparation of water-soluble CNTs,
we covalently linked a neutralizing B cell epitope from method for the functionalization of carbon nanotubes
with a peptide representing a protective B cell epitopethe foot-and-mouth disease virus (FMDV) to mono-
and bis-derivatized CNTs. Immunological character- from the VP1 coat protein of FMDV [15]. Based on this
finding, in this study we sought to evaluate the capacityization of these conjugates revealed that the epitope
was appropriately presented after conjugation to CNTs of mono- and bis-derivatized CNTs to present this B
cell epitope in vivo and examined the possibility of en-for recognition by antibodies as measured by BIAcore
technology. Moreover, peptide-carbon nanotubes elic- hancing its neutralizing potential.
ited strong anti-peptide antibody responses in mice
with no detectable cross-reactivity to the carbon
Results and Discussionnanotubes. However, only the mono-derivitized CNT
conjugate induced high levels of virus-neutralizing an-
Design and Characterization of Peptide-Carbontibodies. These findings highlight for the first time the
Nanotube Conjugatespotential of CNTs to present biologically important
Recently the synthesis of a water-soluble carbon nano-epitopes in an appropriate conformation both in vitro
tube functionalized with a pyrrolidine ring through theand in vivo and open up the possibility for their use in
1,3-dipolar cycloaddition of azomethine ylides was de-vaccine delivery.
scribed [8]. The amino-derivatized carbon nanotube 1
(Figure 1) presenting 0.50 mmol of active group per gramIntroduction
of material (loading), as established by the quantitative
Kaiser test [22], was subsequently used to covalentlyCarbon nanotubes have recently attracted considerable
link a series of peptides by different strategies [15]. Inattention because of their structural properties (e.g.,
particular, a peptide corresponding to the sequencehigh stability, strength, and stiffness, combined with low
141–159 derived from VP1 protein of FMDV was coupleddensity and elastic deformability) and potential biomedi-
through a stable bond to functionalized SWNTs, em-cal and biotechnological applications [1]. Since their
ploying a selective chemical ligation to obtain peptide-discovery [2], there have been several advances in prep-
carbon nanotube 2 (mono-conjugate 2) (Figure 1). Thenaration techniques, which can provide quite pure single-
we explored the possibility of increasing the amountand multiwalled carbon nanotubes (SWNTs and MWNTs)
of peptide around the tube surface by conceiving andin gram quantities. Moreover, the development of oxida-
preparing the conjugated system 3 (Figure 1). This con-tive and synthetic protocols has opened up the possibil-
sists of a single-walled carbon nanotube bearing a dou-ity of generating or attaching functional groups to the
ble functionalization with the FMDV peptide (bis-conju-
gate 3).*Correspondence: a.bianco@ibmc.u-strasbg.fr (A.B), h.partidos@
ibmc.u-strasbg.fr (C.D.P.) To prepare the bis-FMDV peptide-carbon nanotube
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Figure 1. Molecular Structures of the CNT Derivative and Mono- and Bis-Conjugates
3, the free amino groups of SWNT 1 were first derivatized To complement the TEM structural characterization,
a series of bidimensional NMR experiments were ac-using an excess of Boc-Lys(Boc)-OH activated with DIC
(diisopropylcarbodiimide) and HOBt (1-hydroxybenzo- quired in a solution of 9:1 water/t-BuOH-d9. TOCSY and
ROESY spectra allowed the full assignment of the 40triazole) in DMF, followed by the cleavage of Boc (tert-
butyloxycarbonyl) with TFA (trifluoroacetic acid). The amino acids that constitute the peptide moiety of bis-
conjugate 3 (Figure 3). Despite the number of residues,quantitative Kaiser test [22] confirmed that the amount
of amines increased from 0.50 to 0.92 mmol per gram the attribution was facilitated by the presence of a copy
of the same peptide sequence at the external surfaceof carbon nanotube. This derivative displayed a remark-
able solubility in water (150 mg/ml). The free amino of the carbon nanotube. The chemical shift dispersion,
and the intensity and position of NOEs were identicalfunctions were subsequently neutralized with DIEA (di-
isopropylethylamine) and coupled with N-succinimidyl to those of the mono-conjugate 2 that we recently char-
acterized [15]. It is evident that the peptide was linked3-maleimidopropionate in DMF [23]. After stirring over-
night, the excess reagent was removed by addition of to the CNTs as a single chain (mono-conjugate 2) or as
a double chain (bis-conjugate 3) displaying the sameamino-PEGA resin [24] as a scavenger to block the re-
maining carboxylic active ester. A negative Kaiser test secondary structure. Finally, bis-conjugate 3 was char-
acterized by amino acid analysis that confirmed theconfirmed the complete acylation of the amino groups
[25]. The N-terminal acetylated FMDV 141-159 peptide, presence of lysine, necessary to obtain the peptide bis-
adduct, in a correct ratio to the amino acid compositionbearing an additional cysteine at position 1 for the
chemo-selective ligation, was dissolved in water, and of FMDV peptide.
linked to the two maleimido moieties of the wires in 2.6-
fold excess to obtain peptide-carbon nanotube 3 after Recognition of FMDV 141-159 Peptide Linked to
Carbon Nanotubes by a Monoclonal Antibodystirring for 9 hr. Unreacted peptide was removed again
using a scavenger resin. For this purpose we recycled SPR (surface plasmon resonance) measurements allow
the study of antigen-antibody interactions in real timethe previous PEGA resin derivatized with the maleimido
function. The formation of the peptide covalent bond to [28]. To avoid artifacts due to immobilization of one of
the SWNTs was monitored by reverse-phase HPLC as
previously described [15]. The mono-conjugate 2 and
the bis-conjugate 3, to a lower extent, were highly solu-
ble in water, reaching a concentration of 18.0 and 12.5
mg/ml, respectively. To prove the formation of the pep-
tide-SWNT covalent bond, CNT 1 and its derivative with
the deprotected lysine were added to a solution of FMDV
peptide in water. The mixture was analyzed by HPLC
before and after the addition of CNTs without observing
any decrease of peptide concentration due to the spon-
taneous adsorption of peptide at the surface of the wires
by noncovalent interactions. Recent studies have shown
that designed amphiphilic helical peptides or hydropho-
bic peptides derived from phage displayed peptide li-
braries may posses a selective affinity for pristine CNTs
[26, 27].
Bis-conjugate 3 was examined by TEM (transmission
electron microscopy). Figure 2 shows the bundles of
different diameters obtained after deposition of the sam-
Figure 2. TEM Image of Peptide-Carbon Nanotubes 3ple dispersion onto a TEM grid and evaporation of the
solvent. The diameter of the bundles is comprised between 15 and 60 nm.
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Figure 4. Sensorgrams Obtained by Allowing the Analytes to React
with an Anti-Peptide mAb
The association phase required 4 min, the dissociation phase 5 min.
Response with the bis-conjugate 3 (—) (5 M); response with the
mono-conjugate 2 (·····) (5 M); response with free FMDV peptide
(-----) (5 M); response with acetylated CNT 1 (- ·· -) (5 M). RU
value corresponds to the resonance unit (1000 RU  1 ng/mm2 of
analyte).
carrier protein or to a T helper epitope(s) [31]. However,
in the latter case, and particularly in BALB/c mice, it
was observed that not all anti-FMDV 141-159 peptide
antibodies are capable of neutralizing virus infectivity
[31]. Since the peptide was coupled to the CNTs to
circumvent the problem of its poor immunogenicity, we
tested an immunization protocol that has previously
been shown to overcome the requirement of coupling
nonimmunogenic peptides to carrier proteins or to T helper
Figure 3. 2D-NMR Spectra of Peptide-Carbon Nanotube 3 epitopes [32]. Indeed, coinjection of OVA (ovalbumin)
Partial (A) TOCSY and (B) ROESY 1H NMR spectra of peptide-carbon with the FMDV 141-159 peptide renders it immunogenic.
nanotube 3 in H2O/t-BuOH-d9 9:1 solution. Peptide residues are Anti-peptide antibody responses were measured by
numbered from Cys1 to Leu20.
ELISA using the BSA-conjugated FMDV 141-159 peptide
as a solid-phase antigen (Figure 5). In preliminary experi-
the partners [29], we chose to present the anti-FMDV
141-159 peptide mAb to a covalently linked anti-mouse
Fc antibody and to measure the increase in mass due
to the interaction of peptide or carbon nanotube-linked
peptide present in the fluid phase. Corrected sen-
sorgrams are shown in Figure 4. Carbon nanotubes with-
out any bound peptide did not react with the mAb,
whereas free peptide, mono-conjugate 2, and bis-conju-
gate 3 interacted with increasing mass. A qualitative
comparative analysis of the three sensorgrams showed
no differences in the association rate constants and only
a small decrease of the dissociation rate constant for
the bis-conjugate 3, which might be ascribed to the
avidity of the bivalent reagent. Nanotube-linked peptide
thus cover the same conformational space as the free
Figure 5. Anti-Peptide Antibody Responses Following Immuniza-peptide.
tion with Peptides and Peptide-Carbon Nanotubes
Groups of BALB/c mice were coimmunized intraperitoneally with
Induction of Anti-Peptide and FMDV-Neutralizing OVA and free FMDV 141-159 peptide, mono-conjugate 2, or bis-
conjugate 3 in Freund’s adjuvant emulsion. Serum samples col-Antibody Responses Using the Peptide-Carbon
lected 2 weeks after the booster immunization (on day 14 postNanotube Conjugates
priming) were screened by ELISA for the presence of antibodiesImmune responses to FMDV 141-159 peptide are major
using FMDV 141-159 peptide conjugated to BSA (solid bars), controlhistocompatibility complex restricted, and when the
peptide conjugated to BSA (open bars), or CNT 1 functionalized
peptide is injected alone with an adjuvant in BALB/c with maleimido group without peptide (hashed bars) as solid-phase
mice it is not immunogenic [30]. Its capacity to elicit antigens. Data represent mean of log10 antibody titers from five
mice per group  SD.antibodies improves when the peptide is coupled to a
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detectable neutralizing antibodies only in one mouse.
Thus, the increase of the number of epitopes at the
surface of CNTs, although it enhances the immunoge-
nicity of the attached peptide as previously shown [35],
does not improve the neutralizing titers. On the contrary,
it had a detrimental effect, suggesting that the two cop-
ies of the FMDV peptide displayed by the bis-conjugate
3 might interact in vivo and adopt a conformation differ-
ent from that displayed by the native epitope on the
virus. Therefore, the antibody responses do not have
the correct specificity. These findings are in a good
agreement with observations highlighting the limitation
of multiple presentation of epitopes to elicit antibodies
cross-reactive with the native protein [36].
The preferential induction of peptide-specific antibod-Figure 6. Neutralization Indices of Serum Samples of Immunized
ies with enhanced virus neutralizing capacity using theMice
mono-conjugate 2 as immunogen, combined with theSerum samples were collected 2 weeks after the boost of mice coim-
observed nonresponsiveness to the attached carbonmunized intraperitoneally with OVA and free FMDV 141-159 peptide,
mono-conjugate 2, or bis-conjugate 3 in Freund’s emulsion. Data rep- nanotube could be advantageous in the context of vac-
resent mean of antibody titers from five mice per group  SD. cine delivery for two main reasons: (1) it demonstrates
the successful presentation of the attached peptide in
vivo, and (2) it highlights the potential of carbon nano-ments, we have established that the use of conjugated
tubes as an antigen delivery system since no anti-carbonpeptide as a solid-phase antigen increases the sensitiv-
nanotube antibodies were elicited that could influenceity of the ELISA as compared to the nonconjugated pep-
immune responses to the attached peptide (epitopictide (data not shown). The anti-FMDV 141-159 antibody
suppression) [37]. Although the biological relevance ofresponse was further enhanced but not significantly
these antibodies has not been tested in vivo, a recent(p 0.098, according to Student’s t test, a value smaller
study has demonstrated that there was a good correla-than 0.05 was considered significant) when OVA was
tion between serum anti-FMDV neutralizing antibodiescoinjected with the mono-conjugate 2 (Figure 5). How-
and protection [38].ever, when the bis-conjugate 3 was used as an immuno-
gen, the anti-peptide antibody titers were significantly
Significanceelevated (p  0.001) (Figure 5). The observed antibody
responses were peptide specific and were not directed
The study of functionalized carbon nanotubes hasto the functional group linking the FMDV 141-159 pep-
been intensified in recent years due to the realization
tide to the carbon nanotubes. This was confirmed by
that they hold a lot of promise for potential biomedical
the lack of reactivity of serum antibodies with a control and biotechnological applications. Organic modifica-
peptide conjugated to BSA (Figure 5). tion of carbon nanotubes generates multiple sites for
The demonstration that the carbon nanotube peptide the attachment of bioactive molecules, and the nano-
conjugates elicit antibodies of the IgG isotype is com- tube scaffold could be used as a novel delivery system
patible with the notion that these constructs together or as a biosensor. We have recently devised a new
with OVA are sampled by antigen-presenting cells. After method to prepare a series of peptide-carbon nano-
their processing, the bystander help provided by the tube conjugates based on covalently linking a neu-
OVA-specific T helper cells assists the B cells to produce tralizing and protective B cell epitope from the FMDV
antibodies that recognize the FMDV 141-159 peptide. VP1 coat protein to a maleimido-derivatized water-
Furthermore, we did not detect any anti-carbon nano- soluble carbon nanotube using the selective chemical
tube antibodies (Figure 5). In a recent publication, Er- ligation. To increase peptide concentration around the
langer et al. have demonstrated that anti-fullerene tube, we also designed a bis-maleimido derivative for
antibodies [33] can recognize carbon nanotubes [34]. peptide conjugation. The nanotube displayed B cell
However, the fullerene was immunogenic only after be- epitope retained its conformational characteristics
ing coupled to a carrier protein [33]. In our immunization since it was recognized by specific antibodies using
protocol, the carbon nanotube peptide-conjugates were BIAcore technology. More importantly, both the mono-
or bis-maleimido peptide-derivatized carbon nano-coinjected with the carrier protein. Therefore, it appears
tubes elicited strong anti-peptide antibodies, but onlythat the bystander help provided by the carrier (OVA) is
the mono-peptide CNT enhanced significantly the vi-directed to the covalently attached peptide and not to
rus neutralizing antibody titers. Carbon nanotubes didthe carbon nanotubes. This suggests that carbon nano-
not have any detectable immunogenicity. These find-tubes do not possess intrinsic immunogenicity.
ings pave the way for the potential application of car-In subsequent experiments, we tested the capacity
bon nanotubes as a delivery system of candidate vac-of anti-peptide antibodies to neutralize FMDV. As shown
cine antigens.in Figure 6, the mono-conjugate 2 elicited virus-neu-
tralizing antibody responses in all mice, which were sig-
Experimental Procedures
nificantly higher than those induced by the bis-conju-
gate 3 (p  0.009), and control free peptide (p  0.001). SWNTs were purchased from Carbon Nanotechnologies (Houston,
TX). CNT derivative 1 and mono-conjugate 2 were prepared ac-Coimmunization with the control free peptide elicited
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cording to previously reported procedure [8, 15]. NMR spectra were were blocked with 1% (w/v) BSA in phosphate-buffered saline (PBS)
containing 0.05% Tween 20 (PBS-T) at 37C for 2 hr. Followingrecorded on a Bruker ARX 500 MHz spectrometer. The sample was
washing with PBS-T, serial 2-fold dilutions of serum in PBS-T con-dissolved in H2O/t-BuOH-d9 9:1. The spectra were acquired at a
taining 0.25% BSA were made across the plate (final volume 50 l)temperature of 300 K and referenced to the peak of the solvent. The
and plates were incubated at 37C for 1 hr. At the end of the incuba-identification of amino acid spin systems and sequential assignment
tion period, plates were washed with PBS-T and incubated with 50were made using a combination of TOCSY [39] and ROESY [40]
l/well of horseradish peroxidase-conjugated goat anti-mouse IgGexperiments. WATERGATE pulse sequence was applied for the sup-
Fc specific (Jackson ImmunoResearch Laboratories, West Grove,pression of water signal [41]. TEM images were recorded on a Hitachi
PA) for 1 hr at 37C. Unbound conjugate was removed by thorough600 HS instrument at 110kV. Bis-conjugate 3 was suspended in
washing with PBS-T, and the enzymatic activity was determined bydiethyl ether, deposited on the grid (Formvar/carbon support film
adding 150 l/well substrate solution (10% v/v citric phosphateon copper 400 mesh-grid), and analyzed after evaporation of the
buffer at pH 5  0.04% H2O2  90% v/v of a solution containing 72solvent. Amino acid analysis was performed on an Applied Biosys-
ml dimethylsulfoxide 18 ml glycerol 300 mg 3,3,5,5-tetramethyltem model 130A separation system coupled to an Applied Biosys-
benzidine) for 15 min at 37C. The reaction was stopped with 1 Ntem model 420A derivatizer.
HCl, and absorbance was measured at 450 nm. Data are expressed
as antibody titers corresponding to the reciprocal dilution giving anPreparation of Bis-Conjugate 3
OD value equal to 0.2.Carbon nanotube 1 (5.0 mg, 2.5 mol) was dissolved in 1 ml of
dichloromethane and neutralized with DIEA (4 l, 22.5 mol). A
BIAcore Measurementssolution of Boc-Lys(Boc)-OH (2.6 mg, 7.5 mol) in 1 ml of DMF was
The immunological reactivity of the FMDV peptide coupled to carbonactivated with DIC (1.2 l, 7.5 mol) and HOBt (1.2 mg, 7.8 mol)
nanotubes, with the specific monoclonal antibody (mAb) 21  27
for 10 min and subsequently added to carbon nanotube 1 solution.
(generated after injecting mice with conjugated FMDV 147-156 pep-
The mixture was stirred for 3 hr. The solvent was evaporated and
tide [our unpublished data]), was assessed using SPR technology
the product precipitated several times from methanol/diethyl ether
on a BIAcore3000 instrument. Rabbit anti-mouse Fc IgG (BIAcore)
and dried under vacuum. The disappearance of the excess of Boc- was immobilized on a CM5 carboxylated, dextran-coated chip by
Lys(Boc)-OH was followed by thin-layer chromatography (dichloro- the standard amino-coupling procedure recommended by BIAcore.
methane/methanol 8:2). The Boc-protecting group was removed Supernatants of hybridoma cultures secreting the 21  27 anti-
from the functionalized CNT by treatment with 2 ml of trifluoroacetic FMDV peptide mAb and a control mAb of the same isotype (IgG2a)
acid (TFA) overnight. The product was recovered as a brown solid were allowed to react for 5 min at a flow rate of 5 l/min to prepare
after several precipitations in cold diethyl ether. The deprotected the experimental channel and the control channel on the chip, re-
carbon nanotube was dissolved in 1 ml of DMF and neutralized with spectively. The reaction step was followed by the injection of the
DIEA (30.0 l, 169.5 mol). N-succinimidyl 3-maleimidopropionate analytes (solvent, acetylated carbon nanotube 1, mono-conjugate
(13.0 mg, 48.8 mol) dissolved in 1 ml of DMF was added and the 2, bis-conjugate 3 and FMDV peptide in HBS [150 mM NaCl, 10 mM
reaction mixture stirred at room temperature overnight. The excess HEPES, pH 7.4, NP20 at 0.005% v/v]) at a flow rate of 30 l/min for
of maleimido derivative was removed overnight by adding 70 mg 4 min followed by a dissociation phase of 5 min. The anti-mouse
of PEGA-NH2 resin (Novabiochem, La¨ufelfingen, Switzerland), which Fc surface was regenerated by a 10 mM HCl solution passing for
was removed by filtration, and the solvent was evaporated. The 30 s over the two channels. The results expressed as resonance
product was dissolved in methanol and precipitated several times units (RU) were corrected by subtracting from the experimental
with cold diethyl ether. To a solution of the carbon nanotubes func- sensorgram that obtained with the control antibody (to take into
tionalized with the maleimido group (4.0 mg, 2.0 mol) in 2 ml of account nonspecific interactions) and with the solvent to take into
water, Ac-Cys-141GSGVRGDFGSLAPRVARQL159 (Ac-Cys-FMDV pep- account the differential dissociation rate of the two mAbs from the
tide) (11.0 mg, 5.2 mol), prepared by standard Fmoc/tBu (Fmoc, anti-mouse Fc IgG.
fluorenylmethyloxycarbonyl; tBu, tert-butyl) solid phase chemistry
on an automatic peptide synthesizer (15), was added. The reaction In Vitro FMDV Neutralization
was stirred for 9 hr at room temperature and 70 mg of PEGA-NH2 Serum samples were assayed by determining the neutralization in-
dex. Equal volumes of 10-fold dilutions of virus and 1/50 serumresin previously derivatized with N-succinimidyl 3-maleimidopropio-
were incubated at 37C for 20 min before placing the mixtures ontonate were added to remove the excess of peptide after 5 hr. The
monolayers of BHK 21 cells in 96-well plates. After incubation inresin was removed by filtration and the solvent was lyophilized to
the presence of 5% CO2 for 3 days, cells were stained with crystalprovide carbon nanotube (bis-conjugate) 3. The removal of the free
violet-formaldehyde. The difference between the titer of the virusFMDV peptide after the addition of the scavenger resin was moni-
alone and the virus serum mixtures was taken as the neutralizationtored by RP-HPLC on a Macherey-Nagel C18 column using a linear
index of 1/100 dilution of serum (a neutralization index of 2.0 logsgradient of A (0.1% TFA in water) and B (0.08% TFA in acetonitrile),
means that 1/100 dilution of the antiserum reduces the titers of the5%–65% B in 20 min at 1.2 ml/min flow rate.
homologous virus by 2 log10 units).
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